Skip to main content
logo
Bruker Corporation (BRKR)
NASDAQ: BRKR · Real-Time Price · USD
34.56
-1.90 (-5.21%)
At close: Oct 7, 2025, 4:00 PM EDT
34.70
+0.14 (0.41%)
After-hours: Oct 7, 2025, 7:57 PM EDT

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212013 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2013 - 2020
United States Revenue
940.30M938.50M
Log In
Log In
Log In
Upgrade
Germany Revenue
280.60M310.70M
Log In
Log In
Log In
Upgrade
Rest of Europe Revenue
940.10M873.00M
Log In
Log In
Log In
Upgrade
China Revenue
451.00M471.20M
Log In
Log In
Log In
Upgrade
Rest of Asia Pacific Revenue
564.10M518.50M
Log In
Log In
Log In
Upgrade
Total Asia Pacific Revenue
1.02B989.70M
Log In
Log In
Log In
Upgrade
Other Countries Revenue
266.70M254.50M
Log In
Log In
Log In
Upgrade
Revenue (Total)
3.44B3.37B
Log In
Log In
Log In
Upgrade

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212013 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2013 - 2020
BSI BioSpin Revenue
908.50M905.70M
Log In
Log In
Log In
Upgrade
BSI CALID Revenue
1.17B1.09B
Log In
Log In
Log In
Upgrade
BSI Life Science Revenue
2.07B2.00B
Log In
Log In
Log In
Upgrade
BSI Nano Revenue
1.11B1.10B
Log In
Log In
Log In
Upgrade
Total BSI Revenue
3.19B3.10B
Log In
Log In
Log In
Upgrade
BEST Revenue
266.40M283.00M
Log In
Log In
Log In
Upgrade
Eliminations from Revenue
-12.10M-14.10M
Log In
Log In
Log In
Upgrade
Revenue (Other)
-3.19B-3.10B
Log In
Log In
Log In
Upgrade
Revenue (Total)
3.44B3.37B
Log In
Log In
Log In
Upgrade

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212013 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2013 - 2020
BSI BioSpin Operating Income
131.10M157.80M
Log In
Log In
Log In
Upgrade
BSI CALID Operating Income
169.80M180.00M
Log In
Log In
Log In
Upgrade
BSI Life Science Operating Income
300.90M337.80M
Log In
Log In
Log In
Upgrade
BSI Nano Operating Income
-25.30M2.30M
Log In
Log In
Log In
Upgrade
Corporate, Eliminations and Other Operating Income
-122.10M-121.90M
Log In
Log In
Log In
Upgrade
Total BSI Operating Income
153.45M218.20M
Log In
Log In
Log In
Upgrade
BEST Operating Income
30.40M34.90M
Log In
Log In
Log In
Upgrade
Operating Income (Other)
-153.45M-218.20M
Log In
Log In
Log In
Upgrade
Operating Income (Total)
183.90M253.10M
Log In
Log In
Log In
Upgrade

Capital Expenditures

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212013 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2013 - 2020
BSI BioSpin Capital Expenditures
-22.80M
Log In
Log In
Log In
Upgrade
BSI CALID Capital Expenditures
-34.10M
Log In
Log In
Log In
Upgrade
BSI Life Science Capital Expenditures
-56.90M
Log In
Log In
Log In
Upgrade
BSI Nano Capital Expenditures
-19.30M
Log In
Log In
Log In
Upgrade
Corporate Capital Expenditures
-14.80M
Log In
Log In
Log In
Upgrade
Total BSI Capital Expenditures
-91.00M
Log In
Log In
Log In
Upgrade
BEST Capital Expenditures
-24.30M
Log In
Log In
Log In
Upgrade
Updated Aug 4, 2025. Data Source: Fiscal.ai.